Disregolazione neurormonale nelle malattie cardiovascolari
Responsabile del Gruppo
Massimo Volpe
Professore Ordinario
E-mail:
Informazioni
| Struttura | |
| Spin OFF | |
| KET | |
| Keywords | natriuretic peptides, Heart Failure, cardiovascular disease |
| Progetti principali | |
| Altre informazioni |
Componenti del gruppo
| Nome | |
| Speranza Donatella Rubattu | speranzadonatella.rubattu@uniroma1.it |
| Giovanna Gallo | giovanna.gallo@uniroma1.it |
| Giuliano Tocci | giuliano.tocci@uniroma1.it |
Pubblicazioni
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
Natriuretic peptides in heart failure: Current achievements and future perspectives
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Molecular and clinical implications of natriuretic peptides in aortic valve stenosis
Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted Approach
Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation
Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence
ERC
| ERC | Descrizione |